New hope for dementia psychosis: 52-week safety trial of ACP-204 expands
NCT ID NCT07095465
First seen Jan 11, 2026 · Last updated Jun 04, 2026 · Updated 22 times
Summary
This study tests the long-term safety of an experimental drug, ACP-204, for treating psychosis (hallucinations or delusions) in people with Lewy body dementia. About 126 adults who completed a prior study will take the drug for 52 weeks. The main goal is to see what side effects occur.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LEWY BODY DEMENTIA PSYCHOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
ATP Clinical Research Inc.
Irvine, California, 92612, United States
-
Advanced Clinical Research Network, Corp
Miami, Florida, 33135, United States
-
DCC Mladost M- Varna, OOD
Varna, 9000, Bulgaria
-
Hawaii Pacific Neuroscience
Honolulu, Hawaii, 96817, United States
-
Health Synergy Clinical Research, LLC
West Palm Beach, Florida, 33407, United States
-
Homestead Associates in Research Inc
Miami, Florida, 33032, United States
-
Humanity Clinical Research, Corp
Aventura, Florida, 33180, United States
-
K2 Summit Research
Lady Lake, Florida, 32159, United States
-
MediClear Medical & Research Center, Inc.
Miami, Florida, 33165, United States
-
R and H Clinical Research
Stafford, Texas, 77477, United States
-
The Movement Disorder Clinic of Oklahoma
Tulsa, Oklahoma, 74136, United States
-
The Ohio State University, Energy Advancement and Innovation Center
Columbus, Ohio, 43210, United States
-
University of Kansas Medical Center Research Institute Inc.
Kansas City, Kansas, 66160, United States
-
Vestra Clinics s.r.o
Rychnov nad Kněžnou, 51601, Czechia
-
Virginia Commonwealth University (a public institution of higher education)
Richmond, Virginia, 23219, United States
Conditions
Explore the condition pages connected to this study.